A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to
Sponsoring Agencies:
NATL INST OF HLTH NC, NATL SURG ADJUV BREAST & BOWE
